SEQUANA MEDICAL NV (SEQUA.BR) Stock Earnings Estimates
Europe - Euronext Brussels - EBR:SEQUA - BE0974340722 - Common Stock
0.584 EUR
+0.02 (+2.64%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 922.7K 149.04% | 712.2K -22.81% | 105.5K -85.19% | 927K 778.67% | 6.541M 605.61% | 18.746M 186.59% | |
| EBITDA YoY % growth | -27.783M -25.12% | -28.201M -1.50% | -17.608M 37.56% | -19.982M -13.48% | -22.815M -14.18% | -19.055M 16.48% | |
| EBIT YoY % growth | -28.095M -24.24% | -28.862M -2.73% | -18.223M 36.86% | -21.218M -16.44% | -24.617M -16.02% | -20.703M 15.90% | |
| Operating Margin | -3,044.81% | -4,052.54% | -17,272.99% | -2,288.89% | -376.35% | -110.44% | |
| EPS YoY % growth | N/A 3.73% | N/A 7.20% | N/A 56.12% | -0.09 81.63% | -0.12 -27.78% | 0.01 108.70% |
All data in EUR
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.07 53.33% | -0.07 41.67% |
| Revenue Q2Q % growth | 206K 100.00% | 515K |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 53.13% | -0.15 | % | |
| Q1 2024 Q2Q % growth | 48.57% | -0.19 | % | |
| Q4 2023 Q2Q % growth | 9.38% | -0.30 | % | |
| Q3 2023 Q2Q % growth | 6.25% | -0.31 | % | |
| Q2 2023 Q2Q % growth | 52.94% | -0.33 | % | |
| Q1 2023 Q2Q % growth | -16.67% | -0.36 | % | |
| Q4 2022 Q2Q % growth | -6.67% | -0.33 | % | |
| Q3 2022 Q2Q % growth | -0.33 | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 105.5K -72.54% | 103K | 2.5K | 2.43% |
| Q1 2024 Q2Q % growth | -60.00% | 103K | % | |
| Q4 2023 Q2Q % growth | 328K -28.42% | 257.5K | 70.5K | 27.38% |
| Q3 2023 Q2Q % growth | 15.00% | 236.9K | % | |
| Q2 2023 Q2Q % growth | 384.2K -17.29% | 267.8K | 116.4K | 43.47% |
| Q1 2023 Q2Q % growth | 1,566.67% | 257.5K | % | |
| Q4 2022 Q2Q % growth | 458.2K 31.67% | 206K | 252.2K | 122.43% |
| Q3 2022 Q2Q % growth | 1,233.33% | 206K | % | |
| Q2 2022 Q2Q % growth | 464.5K 1,964.44% | 15.45K | 449.05K | 2,906.47% |
| Q4 2021 Q2Q % growth | 348K -5.59% | 15.45K | 332.55K | 2,152.43% |
| Q2 2021 Q2Q % growth | 22.5K -96.22% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 70.33% |
| Revenue | 0% | 0% | 0% | 12.5% |